The function of transporters is of particular interest as transporter dysfunction has been observed in patients with AD [48, 49] and new evidence suggests that efflux transporters such as P-gp and BCRP play an important role in the removal of toxic amyloid species [50–52]. This evidence concerns the gene ABCG2 and Alzheimer disease.